[ Price : $8.95]
CDER's Office of Prescription Drug Promotion (OPDP) says it is monitoring very closely the increasing use of social media platform...[ Price : $8.95]
CDRH launches a new Web page to discuss mission-critical priorities of data and technology innovations and provide information and...[ Price : $8.95]
FDA approves a Getinge PMA for its iCast covered stent system for treating patients with iliac arterial occlusive disease.[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America says a recent FDA draft guidance on oncologic drug development provides limit...[ Price : $8.95]
FDA issues Incyte a complete response letter for Jakafi (ruxolitinib) extended-release tablets, a JAK1/JAK2 inhibitor for once-dai...[ Price : $8.95]
Federal Register notice: FDA establishes a docket to solicit comments on factors that should be considered when reviewing risk eva...[ Price : $8.95]
An FDA advisory committee votes 9 to 0 that Biogens amyotrophic lateral sclerosis drug tofersen should be considered for accelerat...[ Price : $8.95]
As required by the PDUFA 7 agreement, FDA publishes a framework for how it will implement a multifaceted program for using digital...